Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study.

Clinical exercise physiology Pub Date : 2002-02-01

Wendy Demark-Wahnefried, Anne Jacobs Kenyon, Pamela Eberle, Ann Skye, William E Kraus

{"title":"Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study.","authors":"Wendy Demark-Wahnefried, Anne Jacobs Kenyon, Pamela Eberle, Ann Skye, William E Kraus","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>PURPOSE: Weight gain is a common side effect of adjuvant chemotherapy for breast cancer - a side effect that decreases quality of life and also may decrease both disease-free and overall survival. This weight gain also is unique, since patients lose lean body mass while they gain weight. These body composition changes become apparent within six months of diagnosis. METHODS: We explored whether a clinic-based exercise program, which promoted a specialized program of strength training, aerobic activity and a healthful (</=20% fat; fruit, vegetable and calcium-rich) diet could prevent body composition change among Stage I/II premenopausal breast cancer patients who would receive adjuvant chemotherapy. Dual energy x-ray absorptiometry was used to assess body composition at both baseline and at six-month follow-up. Data from patients participating in the intervention (N=9) were compared to data from historic patient controls (N=36). RESULTS: Mean changes (SE) in body weight and composition at 6 month follow-up were as follows among historic patient controls and intervention participants, respectively: body weight +2.2(.4) kg vs. -2.0(1.3) kg (p=.02); % body fat +1.8(1.6)% vs. -1.3(1.2)% (p=.002); lean body mass -0.3(.01) kg vs. +0.1(1.5) kg (p=.80); and fat mass +2.0(.3) kg vs. -1.2(1.5) kg (p=.04). CONCLUSION: Data from this pilot study suggest that exercise/diet interventions may yield promise in preventing adverse chemotherapy-induced weight and body composition changes among young women who receive adjuvant chemotherapy for breast cancer, and that further study is needed. Since over half of the women approached for this intervention study refused on the basis of time and travel requirements, interventions that utilize home-based approaches may be necessary to reach greater numbers and a greater diversity of patients.</p>","PeriodicalId":87433,"journal":{"name":"Clinical exercise physiology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2002-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557655/pdf/nihms11644.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical exercise physiology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

PURPOSE: Weight gain is a common side effect of adjuvant chemotherapy for breast cancer - a side effect that decreases quality of life and also may decrease both disease-free and overall survival. This weight gain also is unique, since patients lose lean body mass while they gain weight. These body composition changes become apparent within six months of diagnosis. METHODS: We explored whether a clinic-based exercise program, which promoted a specialized program of strength training, aerobic activity and a healthful (

本刊更多论文

预防接受辅助化疗的乳腺癌患者出现肌肉松弛性肥胖：一项可行性研究的结果。

目的：体重增加是乳腺癌辅助化疗的常见副作用--这种副作用会降低生活质量，还可能降低无病生存率和总生存率。体重增加也有其特殊性，因为患者在体重增加的同时，瘦体重也会减少。这些身体成分的变化在确诊后六个月内就会显现出来。方法：我们研究了一项以诊所为基础的运动计划，该计划提倡力量训练、有氧运动和健康的饮食（如膳食纤维）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical exercise physiology

自引率

0.00%

发文量